Translation. Region: Russian Federation –
Source: Government of the Russian Federation – Government of the Russian Federation –
An important disclaimer is at the bottom of this article.
Resolution of December 26, 2025 No. 2157
Document
Resolution of December 26, 2025 No. 2157
Starting in 2026, regions will be able to receive federal funding for the purchase of expensive medications for patients with orphan diseases. A resolution has been signed approving the rules for providing subsidies for these purposes.
Regions with limited budgetary resources will be eligible for this support if they demonstrate financial need. Applicants from regional leaders will submit applications to the Ministry of Health.
The federal budget has allocated 9 billion rubles for these purposes in 2026, and 10 billion rubles each in 2027 and 2028.
The possibility of federal subsidies to regions for providing medications to people with rare diseases is established by new provisions of the federal law "On the Fundamentals of Health Protection of Citizens in the Russian Federation." These provisions come into effect on January 1, 2026.
Please note: This information is raw content obtained directly from the source. It represents an accurate account of the source's assertions and does not necessarily reflect the position of MIL-OSI or its clients.